Economiic Home Method Watch Market RSI Search

Immunocore Holdings plc IMCR

Sector:

Healthcare

Industry:

Biotechnology

Description:

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Immunocore Holdings plc website

Recent Quarter:

2024-11-06

Upcoming Quarter:

2025-02-26

Annual Reports

Date2024-02-28
Revenue 249,428,000
Net Income -55,287,000
EPS -1.13
Basic Shares 48,888,975
Diluted Shares 48,888,975
Report Link
Date2023-03-01
Revenue 143,737,000
Net Income -41,224,000
EPS -0.9
Basic Shares 45,714,923
Diluted Shares 45,714,923
Report Link
Date2022-03-03
Revenue 26,520,000
Net Income -131,523,000
EPS -3.1
Basic Shares 42,488,579
Diluted Shares 43,862,850
Report Link
Date2021-03-25
Revenue 30,114,000
Net Income -74,093,000
EPS -2.33
Basic Shares 31,782,885
Diluted Shares 31,782,885
Report Link
Date2019-12-31
Revenue 25,669,000
Net Income -103,931,000
EPS -3.81
Basic Shares 27,306,935
Diluted Shares 27,306,935
Report Link
Date2018-12-31
Revenue 23,654,000
Net Income -71,630,000
EPS -2.62
Basic Shares 27,306,935
Diluted Shares 27,306,935
Report Link

Annual Ratios

Date2023-12-31
PE -60.41
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -52.32
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -8.17
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -13.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -8.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -12.91
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-06
Revenue 80,248,000
Net Income 8,736,000
EPS 0.17
Basic Shares 50,021,939
Diluted Shares 52,808,434
Report Link
Date2024-08-08
Revenue 75,400,000
Net Income -11,616,000
EPS -0.23
Basic Shares 50,014,086
Diluted Shares 50,014,086
Report Link
Date2024-05-08
Revenue 70,502,000
Net Income -24,436,000
EPS -0.49
Basic Shares 49,877,218
Diluted Shares 49,877,218
Report Link
Date2024-02-28
Revenue 105,635,000
Net Income -26,417,000
EPS -0.54
Basic Shares 48,888,975
Diluted Shares 48,888,975
Report Link
Date2023-11-07
Revenue 62,624,940
Net Income 2,315,838
EPS 0.04865207
Basic Shares 54,158,967
Diluted Shares 54,158,967
Report Link
Date2023-05-10
Revenue 60,484,747
Net Income -17,826,057
EPS -0.36723
Basic Shares 48,694,047
Diluted Shares 48,694,047
Report Link
Date2023-03-01
Revenue 55,055,704
Net Income -20,638,627
EPS -0.43262
Basic Shares 48,183,771
Diluted Shares 48,183,771
Report Link
Date2022-11-09
Revenue 48,062,000
Net Income -25,203,000
EPS -0.54
Basic Shares 46,672,222
Diluted Shares 46,672,222
Report Link
Date2022-08-10
Revenue 41,199,000
Net Income 6,228,000
EPS 0.13
Basic Shares 51,443,276
Diluted Shares 51,443,276
Report Link
Date2022-05-11
Revenue 32,002,000
Net Income -6,121,000
EPS -0.14
Basic Shares 43,935,837
Diluted Shares 43,935,837
Report Link
Date2022-03-03
Revenue 22,474,000
Net Income -16,128,000
EPS -0.37
Basic Shares 43,865,799
Diluted Shares 43,865,799
Report Link
Date2021-11-10
Revenue 6,593,000
Net Income -39,389,000
EPS -0.9
Basic Shares 43,669,482
Diluted Shares 43,862,850
Report Link
Date2021-08-11
Revenue 5,924,000
Net Income -30,134,000
EPS -0.69
Basic Shares 43,672,463
Diluted Shares 43,796,084
Report Link
Date2021-05-12
Revenue 5,733,000
Net Income -32,962,000
EPS -0.75
Basic Shares 43,786,088
Diluted Shares 43,786,088
Report Link
Date2021-05-12
Revenue 8,270,000
Net Income -29,038,000
EPS -0.76
Basic Shares 38,451,332
Diluted Shares 38,451,332
Report Link
Date2021-03-25
Revenue 7,420,000
Net Income -18,880,000
EPS -0.49
Basic Shares 38,451,332
Diluted Shares 38,451,332
Report Link
Date2020-09-30
Revenue 6,652,000
Net Income -19,357,000
EPS -0.61
Basic Shares 31,782,885
Diluted Shares 31,782,885
Report Link
Date2020-06-30
Revenue 7,787,000
Net Income -17,217,000
EPS -0.63
Basic Shares 27,306,935
Diluted Shares 27,306,935
Report Link
Date2020-03-31
Revenue 8,255,000
Net Income -18,639,000
EPS -0.68
Basic Shares 27,306,935
Diluted Shares 27,306,935
Report Link
Date2019-12-31
Revenue 5,642,000
Net Income -25,965,000
EPS -0.95
Basic Shares 27,306,935
Diluted Shares 27,306,935
Report Link

Quarterly Ratios

Date2024-09-30
PE 44.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -39.21
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -32.12
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -31.61
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE 303.44
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -40.95
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -28.86
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -21.84
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE 86.80
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -54.99
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -15.47
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -7.01
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -9.97
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -9.38
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -10.23
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -16.10
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -13.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -13.81
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -12.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -8.56
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

47.02

Price:

$32.25

Market Cap:

1,528,774,696

EPS TTM:

-1.09

PE Ratio:

-30.18

PEPSG:

2.3398

Fwd PE:

-70.62

Volume:

365,628

2 Year Price Change

0.523

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: